Search

everythinglearnresearchcommunity

for

Search:↓

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

The placebo microneedle stamp didn't penetrate skin and caused less pain, but blinding was only effective for those with low skin sensitivity.

Vitamin D is needed for metformin to lower prolactin effectively.

Hair cortisol concentration partly reflects HPA axis regulation but doesn't capture all its complexities.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Men with lower 2nd to 4th finger ratios tend to have larger sinus volumes.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Platelet dose in therapies varies greatly due to factors like injected volume and concentration.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Coffee and tea might help hair growth in balding individuals, but side effects and alternative uses are being considered.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

PCOS treatment should be personalized based on individual symptoms and health goals.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.